Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?

@article{Rosenquist2013PrognosticMA,
  title={Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?},
  author={Richard Rosenquist and Diego Cortese and Sujata Bhoi and Larry Mansouri and Rebeqa Gunnarsson},
  journal={Leukemia & lymphoma},
  year={2013},
  volume={54 11},
  pages={2351-64}
}
Chronic lymphocytic leukemia (CLL) is a clinically and biologically heterogeneous disease where the majority of patients have an indolent disease course, while others may experience a far more aggressive disease, treatment failure and poor overall survival. During the last two decades, there has been an intense search to find novel biomarkers that can predict prognosis as well as guide treatment decisions. Two of the most reliable molecular prognostic markers, both of which are offered in… CONTINUE READING